InvestorsHub Logo
Followers 13
Posts 3218
Boards Moderated 0
Alias Born 04/26/2007

Re: None

Wednesday, 10/27/2021 2:00:32 PM

Wednesday, October 27, 2021 2:00:32 PM

Post# of 40501
“During a press briefing on Wednesday, a reporter asked if after the WHO clinical trials on Medigen are completed, would the vaccine receive an emergency use listing (EUL). Health Minister and CECC head Chen Shih-chung (???) responded by saying that first of all, the fact that Medigen was among only two vaccines chosen out of a field of 20, demonstrates that it is an "excellent vaccine and a vaccine with potential for development."

Secondly, Chen said that the WHO will be sponsoring the Phase III trials, covering all the expenses incurred by the research in the three countries participating. Third, the CECC head said that if the results for Medigen are found to be favorable after the trials are completed, "the probability that it becomes a WHO-approved vaccine is very high."

You can be an idiot and believe this same Scenario does not apply to Inovio or just patiently wait for the press release. Doesn’t change the fact that the trial is fully funded.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent INO News